Trias-Sabrià Pere, Dorca Duch Eduard, Molina-Molina Maria, Aso Samantha, Díez-Ferrer Marta, Marín Muñiz Alfredo, Bordas-Martínez Jaume, Sabater Joan, Luburich Patricio, Del Rio Belén, Solanich Xavier, Dorca Jordi, Santos Salud, Suárez-Cuartin Guillermo
Respiratory Department, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain.
Universitat de Barcelona-Campus Bellvitge, L'Hospitalet de Llobregat, Spain.
Front Med (Lausanne). 2022 Apr 19;9:820661. doi: 10.3389/fmed.2022.820661. eCollection 2022.
Patients with coronavirus disease 2019 (COVID-19) can develop severe bilateral pneumonia leading to respiratory failure. Lung histological samples were scarce due to the high risk of contamination during autopsies. We aimed to correlate histological COVID-19 features with radiological findings through lung ultrasound (LU)-guided postmortem core needle biopsies (CNBs) and computerized tomography (CT) scans.
We performed an observational prospective study, including 30 consecutive patients with severe COVID-19. The thorax was divided into 12 explorations regions to correlate LU and CT-scan features. Histological findings were also related to radiological features through CNBs.
Mean age was 62.56 ± 13.27 years old, with 96.7% male patients. Postmortem LU-guided CNBs were performed in 13 patients. Thirty patients were evaluated with both thoracic LU and chest CT scan, representing a total of 279 thoracic regions explored. The most frequent LU finding was B2-lines (49.1%). The most CT-scan finding was ground-glass opacity (GGO, 29%). Pathological CT-scan findings were commonly observed when B2-lines or C-lines were identified through LU (positive predictive value, PPV, 87.1%). Twenty-five postmortem echo-guided histological samples were obtained from 12 patients. Histological samples showed diffuse alveolar damage (DAD) (75%) and chronic interstitial inflammation (25%). The observed DAD was heterogeneous, showing multiple evolving patterns of damage, including exudative (33.3%), fibrotic (33.3%), and organizing (8.3%) phases. In those patients with acute or exudative pattern, two lesions were distinguished: classic hyaline membrane; fibrin "plug" in alveolar space (acute fibrinous organizing pneumonia, AFOP). C-profile was described in 33.3% and presented histological signs of DAD and lung fibrosis. The predominant findings were collagen deposition (50%) and AFOP (50%). B2-lines were identified in 66.7%; the presence of hyaline membrane was the predominant finding (37.5%), then organizing pneumonia (12.5%) and fibrosis (37.5%). No A-lines or B1-lines were observed in these patients.
LU B2-lines and C-profile are predominantly identified in patients with severe COVID-19 with respiratory worsening, which correspond to different CT patterns and histological findings of DAD and lung fibrosis.
2019冠状病毒病(COVID-19)患者可发展为严重的双侧肺炎,导致呼吸衰竭。由于尸检过程中污染风险高,肺组织学样本稀缺。我们旨在通过肺部超声(LU)引导下的尸检芯针活检(CNB)和计算机断层扫描(CT)扫描,将COVID-19的组织学特征与放射学结果相关联。
我们进行了一项观察性前瞻性研究,纳入30例连续的重症COVID-19患者。将胸部分为12个探查区域,以关联LU和CT扫描特征。组织学结果也通过CNB与放射学特征相关联。
平均年龄为62.56±13.27岁,男性患者占96.7%。13例患者进行了尸检LU引导下的CNB。30例患者同时接受了胸部LU和胸部CT扫描,共探查了279个胸部区域。最常见的LU表现是B2线(49.1%)。最常见的CT扫描表现是磨玻璃影(GGO,29%)。当通过LU识别出B2线或C线时,通常会观察到病理性CT扫描结果(阳性预测值,PPV,87.1%)。从12例患者中获取了25份尸检超声引导下的组织学样本。组织学样本显示弥漫性肺泡损伤(DAD)(75%)和慢性间质性炎症(25%)。观察到的DAD是异质性的,呈现多种损伤演变模式,包括渗出期(33.3%)、纤维化期(33.3%)和机化期(8.3%)。在那些具有急性或渗出模式的患者中,可区分出两种病变:经典透明膜;肺泡腔内的纤维蛋白“栓子”(急性纤维蛋白性机化性肺炎,AFOP)。33.3%的患者出现C线表现,并呈现DAD和肺纤维化的组织学征象。主要表现为胶原沉积(50%)和AFOP(50%)。66.7%的患者出现B2线;主要表现为透明膜的存在(37.5%),其次是机化性肺炎(12.5%)和纤维化(37.5%)。这些患者未观察到A线或B1线。
LU B2线和C线主要在呼吸状况恶化的重症COVID-19患者中被识别,它们对应于不同的CT模式以及DAD和肺纤维化的组织学表现。